Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron P Vaughn

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Digestive Diseases and Sciences|July 15, 2018
Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel DiseaseAnna Juncadella, Konstantinos Papamichael, Byron P Vaughn, et al.
Gut Microbes|January 20, 2017
Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel diseaseKrista M Newman, Kevin M Rank, Byron P Vaughn, et al.
Crohn'S & Colitis 360|February 17, 2023
Use of Exclusive Enteral Formula Diet as Adjunctive Therapy for Treatment of a Crohn's Disease FlareLevi M Teigen, Abigail J Johnson, Eugenia Shmidt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2026
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert ReviewMonika Fischer, Byron P Vaughn, Anne F Peery, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2023
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infectionElizabeth S Aby, Radha Rajasingham, Eva A Enns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2022
Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile InfectionElizabeth S Aby, Byron P Vaughn, Eva A Enns, et al.
Digestive Diseases and Sciences|October 21, 2017
Out-of-Pocket Cost Is a Barrier to Therapeutic Drug Monitoring in Inflammatory Bowel DiseaseJames P Campbell, Erin Burton, Shelly Wymer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2026
Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionWilliam Hirsch, Eva A Enns, Alexander Khoruts, et al.
Inflammatory Bowel Diseases|June 23, 2026
Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trialDaphne Moutsoglou, Christopher Staley, Amanda J Kabage, et al.
European Journal of Gastroenterology & Hepatology|August 10, 2020
Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysisAhmed Dirweesh, Chimaobi M Anugwom, Yiting Li, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Digestive Diseases and Sciences|July 15, 2018
Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel DiseaseAnna Juncadella, Konstantinos Papamichael, Byron P Vaughn, et al.
Gut Microbes|January 20, 2017
Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel diseaseKrista M Newman, Kevin M Rank, Byron P Vaughn, et al.
Crohn'S & Colitis 360|February 17, 2023
Use of Exclusive Enteral Formula Diet as Adjunctive Therapy for Treatment of a Crohn's Disease FlareLevi M Teigen, Abigail J Johnson, Eugenia Shmidt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2026
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert ReviewMonika Fischer, Byron P Vaughn, Anne F Peery, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2023
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infectionElizabeth S Aby, Radha Rajasingham, Eva A Enns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2022
Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile InfectionElizabeth S Aby, Byron P Vaughn, Eva A Enns, et al.
Digestive Diseases and Sciences|October 21, 2017
Out-of-Pocket Cost Is a Barrier to Therapeutic Drug Monitoring in Inflammatory Bowel DiseaseJames P Campbell, Erin Burton, Shelly Wymer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2026
Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionWilliam Hirsch, Eva A Enns, Alexander Khoruts, et al.
Inflammatory Bowel Diseases|June 23, 2026
Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trialDaphne Moutsoglou, Christopher Staley, Amanda J Kabage, et al.
European Journal of Gastroenterology & Hepatology|August 10, 2020
Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysisAhmed Dirweesh, Chimaobi M Anugwom, Yiting Li, et al.
Pageof 9